A systematic review of quantitative bias analysis applied to epidemiological research
JM Petersen, LR Ranker… - International journal …, 2021 - academic.oup.com
Background Quantitative bias analysis (QBA) measures study errors in terms of direction,
magnitude and uncertainty. This systematic review aimed to describe how QBA has been …
magnitude and uncertainty. This systematic review aimed to describe how QBA has been …
Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis
M Dal Berto, GT Dos Santos, AV Dos Santos… - Discover Oncology, 2021 - Springer
Tamoxifen (TMX) is used as adjuvant therapy for estrogen receptor-positive (ER+) breast
cancer cases due to its affinity and inhibitory effects. However, about 30% of cases show …
cancer cases due to its affinity and inhibitory effects. However, about 30% of cases show …
NAMPT regulates PKM2 nuclear location through 14‐3‐3ζ: Conferring resistance to tamoxifen in breast cancer
X Ge, Y Zhao, L Dong, J Seng… - Journal of Cellular …, 2019 - Wiley Online Library
The resistance against tamoxifen therapy has become one of the major obstacles in the
clinical treatment of breast cancer. Nicotinamide phosphoribosyltransferase (NAMPT) is an …
clinical treatment of breast cancer. Nicotinamide phosphoribosyltransferase (NAMPT) is an …
[HTML][HTML] BCATc modulates crosstalk between the PI3K/Akt and the Ras/ERK pathway regulating proliferation in triple negative breast cancer
The cytosolic branched chain aminotransferase (BCATc) protein has been found to be
highly expressed in breast cancer subtypes, including triple negative breast cancer (TNBC) …
highly expressed in breast cancer subtypes, including triple negative breast cancer (TNBC) …
Evaluation of quantitative bias analysis in epidemiological research: A systematic review from 2010 to mid‐2023
Objective We aimed to demonstrate the use of quantitative bias analysis (QBA), which
reveals the effects of systematic error, including confounding, misclassification and selection …
reveals the effects of systematic error, including confounding, misclassification and selection …
Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control …
CF Hjorth, AS Nielsen, HT Sørensen, TL Lash… - Acta …, 2019 - Taylor & Francis
Background: Adjuvant tamoxifen therapy approximately halves the risk of recurrence in
estrogen receptor-positive (ER+) breast cancer patients, but many women respond …
estrogen receptor-positive (ER+) breast cancer patients, but many women respond …
[HTML][HTML] Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
Q Wu, H Fan, R Lang, X Li, X Zhang… - BioMed Research …, 2020 - pmc.ncbi.nlm.nih.gov
The protein 14-3-3δ interacts with Trp53 to maintain G2 arrest and thus regulates the cell
cycle. Though dysfunction of 14-3-3δ caused by hyper-methylation of CpG islands was …
cycle. Though dysfunction of 14-3-3δ caused by hyper-methylation of CpG islands was …
Proteomic Investigation of Endocrine Therapy Resistance in Breast Cancer Investigating the Molecular Mechanisms for SERM Resistant Cell Lines Using SILAC …
AY Al-Kabariti - 2022 - bradscholars.brad.ac.uk
Introduction: Breast cancer is the second highest cause of cancer mortality in women
worldwide. Hormonal therapy is considered one of the most effective therapies and is used …
worldwide. Hormonal therapy is considered one of the most effective therapies and is used …
[PDF][PDF] Exprese 14-3-3 izoforem v zdravých a chorobou postižených tkáních
N Gašparik - is.muni.cz
Abstract The 14-3-3 family is a group of important eukaryotic regulatory proteins involved in
diverse cellular functions. They control the subcellular localisation and activity of many …
diverse cellular functions. They control the subcellular localisation and activity of many …